CEL-SCI (CVM) Stock Sees Solid Momentum After Week Long Extended Rally

CEL-SCI Corporation (NYSE: CVM) stock is going wild as the stock has recovered very well in just a week.

CEL-SCI (CVM) Stock Sees Solid Momentum After Week Long Extended Rally

On Thursday morning, the stock went up 13.50% to $22.76, extending its weekly rally to almost 45%. CVM was the hottest biotech stock in late January when the stock went up once whopping 175% on January 27th on a Reddit-driven rally, although the stock ended the session with a gain of 72%. Since then the stock went into the correction and slipped back to $13.85 by March late. Considering the solid recovery over the past few sessions looks like the momentum is back into the stock.

Related:  InspireMD (NSPR) Moves Back Above $1 Mark: Up 125% YTD

CVM stock may find catalyst related to moving on developments regarding its investigational therapy Multikine, which may be a potential treatment for head and neck cancer. CEL-SCI is currently finalizing its Phase 3 trial results. So, if you like to take risks and love to trade biotech stock, then CVM may be a momentum biotech play.

Jack Dawkins

Finance and Tech Contributor